Comment on AbbVie (ABBV) Stock Rises Today on Bullish Analyst Notes

AbbVie (ABBV) Stock Rises Today on Bullish Analyst Notes

NEW YORK (TheStreet) -- Shares of AbbVie rose 0.72% to $61.64 in afternoon trading Tuesday after a pair of bullish comments from two analysts. Deustche Bank spots a potential catalyst in AbbVie's partnership with Galapagos on a treatment for rheumatoid arthritis: AbbVie & Galapagos are expected to release data for their JAK-1, Filgotinib in mid-April (DARWIN-1) in Rheumatoid Arthritis (RA).

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News